(1)
[Budget Impact Analysis of Idarucizumab for the Management of Patients Treated With Dabigatran in Emergency Urgent Situations in Italy]. FE 2016, 17 (2), 47-58. https://doi.org/10.7175/fe.v17i2.1243.